[Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)].
A group of patients with metastatic breast cancer treated by a distinct drug regimen is analyzed with special respect to clinical and psychological problems. The range of remissions in this study was similar to literature dates. General limitations of indication for cytostatic drugs and of long-time-therapy are discussed. The possible relations of histologic type of primary carcinoma to the efficiency of chemotherapy is mentioned.
D000230:Adenocarcinoma / Q000188:drug therapy; D002293:Adenocarcinoma, Scirrhous / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002277:Carcinoma / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D013899:Thoracic Neoplasms / Q000188:drug therapy; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014750:Vincristine; D003520:Cyclophosphamide; D005472:Fluorouracil; D011241:Prednisone; D008727:Methotrexate
Erfahrungen mit der medikamentösen Behandlung von Spätstadien beim metastasierenden Mammakarzinom